Process for the preparation of pharmaceutical compositions for the sustained release of somatostatin analogs

Details for Australian Patent Application No. 2011206728 (hide)

Owner IPSEN PHARMA S.A.S.

Inventors Montes, Martin; Loughman, Thomas Ciaran; Roume, Chantal; Cherif-Cheikh, Roland

Agent Watermark

Pub. Number AU-A-2011206728

PCT Pub. Number WO2011/085957

Priority 61/294,644 13.01.10 US

Filing date 11 January 2011

Wipo publication date 21 July 2011

International Classifications

A61K 9/00 Medicinal preparations characterised by special physical form

A61K 9/19 Medicinal preparations characterised by special physical form - lyophilised

A61K 38/31 Medicinal preparations containing peptides - Somatostatins

A61K 47/12 Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Carboxylic acids

Event Publications

30 August 2012 PCT application entered the National Phase

  PCT publication WO2011/085957 Priority application(s): WO2011/085957

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011206736-Electrolyte formulations

2011206717-Methods for the preparation of indazole-3-carboxyclic acid and N- (S)-1-azabicyclo[2.2.2]oct-3-yl-1H-indazole-3-carboxamide hydrochloride salt